Abstract
Novel 5-aza-ellipticine derivatives were synthesized and tested as antitumor agents. The new compounds were prepared more readily than the analogous ellipticine derivatives, which are known to be potent anti-tumor agents Although the novel 5-aza-ellipticine derivatives are not as biologically active as their corresponding ellipticine analogues, the new compounds represent a new, readily accessible class of heteroaromatic catalytic inhibitors of topoisomerase II and possible anti-tumor agents.
Publication types
-
Research Support, N.I.H., Intramural
MeSH terms
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacology
-
Aza Compounds / chemical synthesis
-
Aza Compounds / pharmacology
-
Cell Line
-
Cell Survival / drug effects
-
Ellipticines / chemical synthesis*
-
Ellipticines / pharmacology*
-
Humans
-
Inhibitory Concentration 50
-
Structure-Activity Relationship
-
Topoisomerase II Inhibitors*
Substances
-
Antineoplastic Agents
-
Aza Compounds
-
Ellipticines
-
Topoisomerase II Inhibitors